1096 related articles for article (PubMed ID: 17870108)
41. Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats.
Takeda H; Yamazaki Y; Igawa Y; Kaidoh K; Akahane S; Miyata H; Nishizawa O; Akahane M; Andersson KE
Neurourol Urodyn; 2002; 21(6):558-65. PubMed ID: 12382247
[TBL] [Abstract][Full Text] [Related]
42. Effect of the potassium channel opener WAY-133537 on the overactive bladder of spinalized rats.
Elzayat E; Khaled S; Kashiwabara T; Elhilali M; Corcos J
Neurourol Urodyn; 2006; 25(7):808-14. PubMed ID: 16804922
[TBL] [Abstract][Full Text] [Related]
43. Antimuscarinics suppress adenosine triphosphate and prostaglandin E2 release from urothelium with potential improvement in detrusor overactivity in rats with cerebral infarction.
Yokoyama O; Tanaka I; Kusukawa N; Yamauchi H; Ito H; Aoki Y; Oyama N; Miwa Y; Akino H
J Urol; 2011 Jun; 185(6):2392-7. PubMed ID: 21511278
[TBL] [Abstract][Full Text] [Related]
44. Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats.
Yokoyama O; Yusup A; Miwa Y; Oyama N; Aoki Y; Akino H
J Urol; 2005 Nov; 174(5):2032-6. PubMed ID: 16217388
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
Kuo HC
J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
[TBL] [Abstract][Full Text] [Related]
46. Overactive bladder inhibition in response to pelvic floor muscle exercises.
Shafik A; Shafik IA
World J Urol; 2003 May; 20(6):374-7. PubMed ID: 12682771
[TBL] [Abstract][Full Text] [Related]
47. Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction.
Lee T; Hedlund P; Newgreen D; Andersson KE
J Urol; 2007 Apr; 177(4):1562-7. PubMed ID: 17382779
[TBL] [Abstract][Full Text] [Related]
48. Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity.
Okutsu H; Matsumoto S; Ohtake A; Suzuki M; Sato S; Sasamata M; Uemura H
J Urol; 2011 Dec; 186(6):2470-7. PubMed ID: 22019173
[TBL] [Abstract][Full Text] [Related]
49. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms and urodynamic effects of a potent and selective EP4 receptor antagonist, MF191, on cyclophosphamide and prostaglandin E2-induced bladder overactivity in rats.
Chuang YC; Tyagi P; Huang CC; Chancellor MB; Yoshimura N
BJU Int; 2012 Nov; 110(10):1558-64. PubMed ID: 22452546
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
[TBL] [Abstract][Full Text] [Related]
52. alpha1-Adrenergic mechanism in diabetic urethral dysfunction in rats.
Torimoto K; Hirao Y; Matsuyoshi H; de Groat WC; Chancellor MB; Yoshimura N
J Urol; 2005 Mar; 173(3):1027-32. PubMed ID: 15711370
[TBL] [Abstract][Full Text] [Related]
53. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
54. Detrusor internal and external work in relation to passive urethral resistance in a canine model of the lower urinary tract.
Lecamwasam HS; Sullivan MP; Cravalho EG; Yalla SV
Neurourol Urodyn; 1996; 15(5):529-43; discussion 544. PubMed ID: 8857620
[TBL] [Abstract][Full Text] [Related]
55. Effects of propiverine and its metabolite propiverine-N-oxide on bladder contraction and salivation in mini pigs.
Scheepe JR; Braun PM; Jünemann KP; Alken P
Urol Int; 2008; 81(4):468-73. PubMed ID: 19077412
[TBL] [Abstract][Full Text] [Related]
56. Muscarinic receptor antagonists for overactive bladder.
Abrams P; Andersson KE
BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
[TBL] [Abstract][Full Text] [Related]
57. Bladder outlet obstruction induced expression of prostaglandin E2 receptor subtype EP4 in the rat bladder: a possible counteractive mechanism against detrusor overactivity.
Beppu M; Araki I; Yoshiyama M; Du S; Kobayashi H; Zakoji H; Takeda M
J Urol; 2011 Dec; 186(6):2463-9. PubMed ID: 22019172
[TBL] [Abstract][Full Text] [Related]
58. Diabetic urethropathy compounds the effects of diabetic cystopathy.
Yang Z; Dolber PC; Fraser MO
J Urol; 2007 Nov; 178(5):2213-9. PubMed ID: 17870107
[TBL] [Abstract][Full Text] [Related]
59. Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity.
Liu HP; Chen GL; Liu P; Xu XP
BJU Int; 2009 Dec; 104(11):1752-7. PubMed ID: 19493262
[TBL] [Abstract][Full Text] [Related]
60. Effects of opioid subtypes on detrusor overactivity in rats with cerebral infarction.
Nagasaka Y; Yokoyama O; Komatsu K; Ishiura Y; Nakamura Y; Namiki M
Int J Urol; 2007 Mar; 14(3):226-31; discussion 232. PubMed ID: 17430260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
